Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.

Serce NB, Boesl A, Klaman I, von Serényi S, Noetzel E, Press MF, Dimmler A, Hartmann A, Sehouli J, Knuechel R, Beckmann MW, Fasching PA, Dahl E.

BMC Cancer. 2012 Dec 13;12:597. doi: 10.1186/1471-2407-12-597.

2.

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.

Bektas N, Noetzel E, Veeck J, Press MF, Kristiansen G, Naami A, Hartmann A, Dimmler A, Beckmann MW, Knüchel R, Fasching PA, Dahl E.

Breast Cancer Res. 2008;10(4):R58. doi: 10.1186/bcr2117. Epub 2008 Jul 15.

3.

Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Aug 25;9:298. doi: 10.1186/1471-2407-9-298.

4.

Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, Denkert C, Dahl E, Sehouli J.

Gynecol Oncol. 2007 Nov;107(2):266-73. Epub 2007 Aug 14.

PMID:
17698176
5.

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

Bektas N, Haaf At, Veeck J, Wild PJ, Lüscher-Firzlaff J, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2008 Feb 6;8:42. doi: 10.1186/1471-2407-8-42.

6.

Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.

Xu L, Peng S, Huang Q, Liu Y, Jiang H, Li X, Wang J.

Oncol Rep. 2016 Oct;36(4):1981-8. doi: 10.3892/or.2016.5051. Epub 2016 Aug 25.

PMID:
27573674
7.

Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.

Wei CY, Tan QX, Zhu X, Qin QH, Zhu FB, Mo QG, Yang WP.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14619-29. eCollection 2015.

8.

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.

O Leary PC, Penny SA, Dolan RT, Kelly CM, Madden SF, Rexhepaj E, Brennan DJ, McCann AH, Pontén F, Uhlén M, Zagozdzon R, Duffy MJ, Kell MR, Jirström K, Gallagher WM.

BMC Cancer. 2013 Apr 2;13:175. doi: 10.1186/1471-2407-13-175.

9.

Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.

Zhao Y, Chen S, Gou WF, Xiao LJ, Takano Y, Zheng HC.

Tumour Biol. 2014 Mar;35(3):1955-64. doi: 10.1007/s13277-013-1261-6. Epub 2013 Oct 17.

PMID:
24132590
10.

Expression of cyclin kinase subunit 2 in human breast cancer and its prognostic significance.

Wang J, Xu L, Liu Y, Chen J, Jiang H, Yang S, Tan H.

Int J Clin Exp Pathol. 2014 Dec 1;7(12):8593-601. eCollection 2014.

11.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

12.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
13.

Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.

Wang WP, Yan XL, Li WM, Ni YF, Zhao JB, Lu Q, Wang XJ, Sun Y, Chen P, Yan BY, Cui Y, Zhang ZP, Li XF.

Pathol Res Pract. 2015 Dec;211(12):939-47. doi: 10.1016/j.prp.2015.09.010. Epub 2015 Sep 10.

PMID:
26554593
14.

Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.

Shen H, Cai M, Zhao S, Wang H, Li M, Yao S, Jiang N.

Tumour Biol. 2014 Oct;35(10):10259-66. doi: 10.1007/s13277-014-2216-2. Epub 2014 Jul 17.

PMID:
25030735
15.

Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.

Hazelbag S, Kenter GG, Gorter A, Fleuren GJ.

Int J Cancer. 2004 Dec 20;112(6):1020-8.

16.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329
17.

Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.

Zafrakas M, Chorovicer M, Klaman I, Kristiansen G, Wild PJ, Heindrichs U, Knüchel R, Dahl E.

Int J Cancer. 2006 Mar 15;118(6):1453-9.

18.
19.

Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Shubbar E, Kovács A, Hajizadeh S, Parris TZ, Nemes S, Gunnarsdóttir K, Einbeigi Z, Karlsson P, Helou K.

BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1.

20.

Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.

Berdel B, Nieminen K, Soini Y, Tengström M, Malinen M, Kosma VM, Palvimo JJ, Mannermaa A.

BMC Cancer. 2012 Nov 14;12:516. doi: 10.1186/1471-2407-12-516.

Supplemental Content

Support Center